Does Your Trial Simulator Know What the Drug Does? An Intervention-Blind Test of Interventional Validity on 7,207 Registered Trials
Read the original on arXiv AI →The study evaluates the interventional validity of clinical trial simulators by creating an intervention‑blind reference model that withholds intervention identifiers. Using 9,996 within‑trial contrasts from 7,207 phase 2/3 trials, the authors measure how much a simulator’s accuracy improves when it knows the intervention. Results show that a registry‑trained gradient‑boosting model performs poorly on interventional skill, while a large language model reading only the protocol achieves positive interventional skill, and perturbation tests confirm that the model relies on the intervention information.
Machine-generated by The Flow from the publisher's headline and feed description — not written or checked by a human. The full article lives at arXiv AI.